GPX5: A Potential Drug Target for Male Reproductive Function (G2880)

Target Name: GPX5

NCBI ID: G2880

GPX5

GPX5: A Potential Drug Target for Male Reproductive Function

Growth and development are essential processes in the male reproductive system, and androgens play a critical role in these processes. In addition to their role in promoting male sexual function, androgens also play a key role in maintaining tissue structure and function, including the development and maintenance of the vas deferens. The androgen-related protein (GPX5) is a key protein involved in these processes, and is currently being targeted as a potential drug target for various reproductive and urologic disorders.

GPX5:

GPX5 is a protein that is expressed in a variety of tissues, including testes, prostate, ovaries, and fat cells. It is a 21-kDa protein that is characterized by a unique domain structure that includes a conserved N-terminal region, a 尾-sheet, and a C-terminal region. The N-terminal region includes a putative N-methyltransferase (NMT) domain that is involved in modifying the stability of the protein. The 尾-sheet is composed of 12 transmembrane伪-helices and is thought to play a role in the protein's stability and localization to different tissues. The C-terminal region includes a unique extension that is involved in the protein's stability and may also be involved in its interactions with other proteins.

Function:

GPX5 is involved in a variety of processes that are important for male reproductive function, including the development and maintenance of the vas deferens. In addition to its role in promoting the formation of new vas deferens during fetal development, GPX5 is also involved in the regulation of the growth and differentiation of the vas deferens epithelial cells. This is done through the regulation of cell proliferation, differentiation, and survival, as well as the regulation of cell-cell and cell-tissue interactions.

Drug targeting:

GPX5 is a potential drug target due to its involvement in the regulation of male reproductive function and its unique structure. Several studies have identified potential drug targets for GPX5, including those that target the N-terminal MT domain, the 尾-sheet, and the C-terminal extension. These targets include small molecules, such as inhibitors of the androgen receptor, as well as antibodies that can specifically bind to GPX5. Additionally, researchers have also used techniques such as RNA interference and CRISPR/Cas9 genome editing to knockdown or activate the GPX5 gene in order to study its role in different reproductive processes.

Conclusion:

GPX5 is a protein that is involved in a variety of processes that are important for male reproductive function. Its unique structure and the involvement of several potential drug targets make it an attractive target for research into the development of new treatments for reproductive and urologic disorders. Further studies are needed to fully understand the role of GPX5 in these processes and to develop effective treatments.

Protein Name: Glutathione Peroxidase 5

Functions: Protects cells and enzymes from oxidative damage, by catalyzing the reduction of hydrogen peroxide, lipid peroxides and organic hydroperoxide, by glutathione. May constitute a glutathione peroxidase-like protective system against peroxide damage in sperm membrane lipids

The "GPX5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPX5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets